CF and non-CF bronchiectasis

CF and non-CF bronchiectasis

First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers
Alison Mackie, Juliane Rascher, Marion Schmid, Verena Endriss, Tobias Brand, Wolfgang Seibold

ERJ Open Research Jan 2021, 7 (1) 00447-2020; DOI: 10.1183/23120541.00447-2020
Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
Susannah J. King, Dominic Keating, Elyssa Williams, Eldho Paul, Brigitte M. Borg, Felicity Finlayson, Brenda M. Button, John W. Wilson, Tom Kotsimbos

ERJ Open Research Jan 2021, 7 (1) 00203-2020; DOI: 10.1183/23120541.00203-2020
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
Michael D. Kim, Nathalie Baumlin, John S. Dennis, Makoto Yoshida, Adrian Kis, Carolina Aguiar, Andreas Schmid, Eliana Mendes, Matthias Salathe

ERJ Open Research Jan 2021, 7 (1) 00394-2020; DOI: 10.1183/23120541.00394-2020
Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes
Grace Y. Lam, Jodi Goodwin, Pearce G. Wilcox, Bradley S. Quon

ERJ Open Research Jan 2021, 7 (1) 00475-2020; DOI: 10.1183/23120541.00475-2020
Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions
Laura K. Fawcett, Claire E. Wakefield, Sheila Sivam, Peter G. Middleton, Peter Wark, John Widger, Adam Jaffe, Shafagh A. Waters

ERJ Open Research Jan 2021, 7 (1) 00448-2020; DOI: 10.1183/23120541.00448-2020
Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia
Alex Gileles-Hillel, Hagar Mor-Shaked, David Shoseyov, Joel Reiter, Reuven Tsabari, Avigdor Hevroni, Malena Cohen-Cymberknoh, Israel Amirav, Shuli Brammli-Greenberg, Amjad Horani, Eitan Kerem, Oded Breuer

ERJ Open Research Oct 2020, 6 (4) 00213-2020; DOI: 10.1183/23120541.00213-2020
Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis
Peter Nickolaus, Birgit Jung, Juan Sabater, Samuel Constant, Abhya Gupta

ERJ Open Research Oct 2020, 6 (4) 00429-2020; DOI: 10.1183/23120541.00429-2020
An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CF^TM 1
Christopher H. Goss, Raksha Jain, Wolfgang Seibold, Anne-Caroline Picard, Ming-Chi Hsu, Abhya Gupta, Isabelle Fajac

ERJ Open Research Oct 2020, 6 (4) 00395-2020; DOI: 10.1183/23120541.00395-2020
Parasexual recombination enables Aspergillus fumigatus to persist in cystic fibrosis
Tobias Engel, Paul E. Verweij, Joost van den Heuvel, Dechen Wangmo, Jianhua Zhang, Alfons J.M. Debets, Eveline Snelders

ERJ Open Research Oct 2020, 6 (4) 00020-2020; DOI: 10.1183/23120541.00020-2020
Current therapies for gastro-oesophageal reflux in the setting of chronic lung disease: state of the art review
Melissa J. McDonnell, Eoin B. Hunt, Chris Ward, Jeffrey P. Pearson, Daniel O'Toole, John G. Laffey, Desmond M. Murphy, Robert M. Rutherford

ERJ Open Research Oct 2020, 6 (4) 00190-2019; DOI: 10.1183/23120541.00190-2019

Main menu

User menu

Search

CF and non-CF bronchiectasis

Pages

Contact us